0B68 Lu, Bo - Thomas Jefferson University - Thomas Jefferson University
bxl017

Bo Lu, MD

Contact Dr. Lu

G-301 Bodine Cancer Center
111 S. 11th Street
Philadelphia, PA 19107

(215) 955-6705
(215) 503-0013 fax

Most Recent Peer-reviewed Publications

  1. Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab
  2. Opportunities and challenges in the era of molecularly targeted agents and radiation therapy
  3. ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinoma
  4. ALK inhibitor PF02341066 (Crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALK
  5. Higher levels of c-Met expression and phosphorylation identify cell lines with increased sensitivity to AMG-458, a novel selective c-Met inhibitor with radiosensitizing effects
  6. Molecular profiling to optimize treatment in non-small cell lung cancer: A review of potential molecular targets for radiation therapy by the translational research program of the Radiation Therapy Oncology Group
  7. Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer
  8. Heat shock protein 90 inhibition: Rationale and clinical potential
  9. Occult nodal metastasis in non-small-cell lung cancer: Implications for the radiation oncologist
  10. Guidelines for the use and interpretation of assays for monitoring autophagy
  11. The Aurora Kinase A polymorphisms are not associated with recurrencefree survival in prostate cancer patients
  12. Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells
  13. Therapeutic targets in head and neck squamous cell carcinoma: Identification, evaluation, and clinical translation
  14. BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitro
  15. An approach for online evaluations of dose consequences caused by small rotational setup errors in intracranial stereotactic radiation therapy
  16. A novel bioluminescence orthotopic mouse model for advanced lung cancer
  17. The zinc ionophore PCI-5002 radiosensitizes non-small cell lung cancer cells by enhancing autophagic cell death
  18. PM02734 (elisidepsin) induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of death-associated protein kinase
  19. MLN8054, A small molecule inhibitor of Aurora kinase A, sensitizes androgen-resistant prostate cancer to radiation
  20. Editorial: Cancer stem cells
0